文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

静脉过量超声分级系统(VExUS)评估的全身静脉淤血在综合ICU队列中的患病率及其与急性肾损伤的相关性:一项前瞻性多中心研究

Prevalence of systemic venous congestion assessed by Venous Excess Ultrasound Grading System (VExUS) and association with acute kidney injury in a general ICU cohort: a prospective multicentric study.
PubMed 文献 · Crit Care · 2023-06-08
一句话结论综合ICU中VExUS≥2的中重度静脉淤血患病率低(16%和6%),入ICU时VExUS评分与急性肾损伤或28天死亡率无显著关联。

这项前瞻性观察性研究纳入145例成人ICU患者,在入ICU 24小时内、第1天后(24–48小时)、第2天后(48–72小时)及ICU最后一天共4次测量VExUS和血流动力学参数,评估ICU第一周急性肾损伤(AKI)患病率和28天死亡率。结果显示VExUS评分2分(中度淤血)和3分(重度淤血)的患者比例分别为16%和6%,研究期间患病率无变化。入ICU时VExUS评分与AKI(p=0.136)或28天死亡率(p=0.594)无显著关联;入ICU时VExUS≥2与AKI(OR 0.499,95%CI 0.21–1.17,p=0.109)及28天死亡率(OR 0.75,95%CI 0.2–2.8,p=0.669)均无显著关联,第1天和第2天测量的结果类似。作者认为在综合ICU中早期VExUS评估的全身静脉淤血与AKI或28天死亡率无关。

要点

  • 综合ICU成人患者中,VExUS评分2分(中度淤血)占16%,3分(重度淤血)占6%,研究期间患病率无变化。
  • 入ICU时VExUS评分与AKI无显著关联(p=0.136),与28天死亡率也无显著关联(p=0.594)。
  • 入ICU时VExUS≥2与AKI无显著关联(OR 0.499,95%CI 0.21–1.17,p=0.109),与28天死亡率也无显著关联(OR 0.75,95%CI 0.2–2.8,p=0.669)。
  • 第1天和第2天测量的VExUS评分与AKI及28天死亡率的结果与入ICU时类似。
  • 在综合ICU中,早期VExUS评估的全身静脉淤血与AKI或28天死亡率无关,与心脏ICU人群的既往报道不同。

适用人群与场景

  • 成人综合ICU患者,入ICU 24小时内纳入。

诊断标准与关键阈值

  • VExUS评分2分定义为中度淤血,3分定义为重度淤血;VExUS≥2分作为淤血分组阈值。

研究设计与关键结果

  • 研究类型为前瞻性观察性研究,纳入145例成人综合ICU患者,在入ICU 24小时内、第1天后(24–48小时)、第2天后(48–72小时)及ICU最后一天共4次测量VExUS和血流动力学参数,评估ICU第一周AKI患病率和28天死亡率。
  • VExUS评分2分(中度淤血)患者占16%,3分(重度淤血)占6%,研究期间患病率无变化。
  • 入ICU时VExUS评分与AKI无显著关联(p=0.136),与28天死亡率无显著关联(p=0.594)。
  • 入ICU时VExUS≥2与AKI无显著关联(OR 0.499,95%CI 0.21–1.17,p=0.109),与28天死亡率无显著关联(OR 0.75,95%CI 0.2–2.8,p=0.669)。
  • 第1天和第2天测量的VExUS评分与AKI及28天死亡率的结果与入ICU时类似。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在综合ICU成人患者中,早期VExUS评估的全身静脉淤血与AKI或28天死亡率无关,作者据此认为VExUS评分不应用于预测此类结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The importance of assessing venous congestion in ICU patients is widely acknowledged, but its study is hampered by the lack of a practical evaluation tool. The Venous Excess Ultrasound Grading System (VExUS), based on a semi-quantitative combined ultrasound assessment, has been associated with acute kidney injury (AKI) in cardiac ICU patients. The objectives of this study were to assess the prevalence of congestion using VExUS in general ICU patients, and to evaluate the association between VExUS, AKI and death.

METHODS: This prospective, observational study included adult patients within 24 h of ICU admission. VExUS and hemodynamic parameters were measured four times during the ICU stay: within 24 h of ICU admission, after day 1 (between 24 and 48 h), after day 2 (between 48 and 72 h), and last day of ICU stay. The prevalence of AKI during the first week in ICU and 28-day mortality were assessed.

RESULTS: Among the 145 patients included, the percentage of patients with a VExUS score of 2 (moderate congestion) and 3 (severe congestion) was 16% and 6%, respectively. The prevalence did not change over the study period. There was no significant association between admission VExUS scores and AKI (p = 0.136) or 28-day mortality (p = 0.594). Admission VExUS ≥ 2 was not associated with AKI (OR 0.499, CI95% 0.21-1.17, p = 0.109) nor 28-day mortality (OR 0.75, CI95% 0.2-2.8, p = 0.669). The results were similar for VExUS scores measured at day 1 and day 2.

CONCLUSIONS: In general ICU cohort the prevalence of moderate to severe venous congestion was low. Early assessment of systemic venous congestion using VExUS scores was not associated with the development of AKI or with 28-day mortality.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Andrei S, Bahr PA, Nguyen M, et al. Prevalence of systemic venous congestion assessed by Venous Excess Ultrasound Grading System (VExUS) and association with acute kidney injury in a general ICU cohort: a prospective multicentric study. Crit Care. 2023. PMID: 37291662. doi:10.1186/s13054-023-04524-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。